Published references involving DSIP are limited to non-clinical investigations focused on circadian rhythm modeling, stress-response signaling, neuroendocrine modulation, and peptide interaction behavior within experimental systems
As you approach your goal, the conversation with your provider will shift from how much weight can I lose? to how do I maintain this new, healthy weight? Sustainable weight loss is about more than just a number on a scale
GLP-1 agonists, in contrast, generally do not lead to excessively low blood sugar levels
Diabetes 70(2):415422
Because we do things differently
Verified Patient GLP-1 receptor agonists have been prescribed (on-and-off label) for weight management, including obesity, along with a reduced caloric diet and increased physical activity